Differential gene expression associated with inflammation and blood pressure regulation induced by concentrated ambient particle exposure

Inhalation Toxicology

Volumn 23, Issue 14, 2011, Pages 897-905

  Hasegawa, Go ^a   Hirano, Masato ^b   Ishihara, Yoko ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN ENVIRONMENTAL SANITATION CENTER   (Japan)

Author keywords

Blood pressure; Concentrated ambient particles; Gene expression; Inflammation; Inhalation; Microarray analysis; Particle matter

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C4A; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN RECEPTOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1BETA; NEUROPEPTIDE Y; RANTES;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; COMPLEMENT ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; DNA MICROARRAY; DOWN REGULATION; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL TEMPERATURE; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; HEART VENTRICLE; INFLAMMATION; LEUKOCYTE ACTIVATION; MALE; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; UPREGULATION;

AGING; AIR POLLUTANTS; ANIMALS; BLOOD PRESSURE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART VENTRICLES; LUNG; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PARTICULATE MATTER; PNEUMONIA; RATS; RATS, INBRED F344;

EID: 82655178782     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2011.625058     Document Type: Article

References (21)

1. Anderson HR, Atkinson RW, Bremner SA, Marston L. 2003. Particulate air pollution and hospital admissions for cardiorespiratory diseases: are the elderly at greater risk? Eur Respir J Suppl 40:39s-46s.
2. Dagher Z, Garçon G, Gosset P, Ledoux F, Surpateanu G, Courcot D, Aboukais A, Puskaric E, Shirali P. 2005. Pro-inflammatory effects of Dunkerque city air pollution particulate matter 2.5 in human epithelial lung cells (L132) in culture. J Appl Toxicol 25:166-175.
3. Elder AC, Gelein R, Finkelstein JN, Cox C, Oberdörster G. 2000. Pulmonary inflammatory response to inhaled ultrafine particles is modified by age, ozone exposure, and bacterial toxin. Inhal Toxicol 12 Suppl 4:227-246.
4. Lippmann M, Ito K, Nádas A, Burnett RT. 2000. Association of particulate matter components with daily mortality and morbidity in urban populations. Res Rep Health Eff Inst 95:5-72, discussion 73-82.
5. Michalkiewicz M, Zhao G, Jia Z, Michalkiewicz T, Racadio MJ. 2005. Central neuropeptide Y signaling ameliorates N(omega)-nitro-Larginine methyl ester hypertension in the rat through a Y1 receptor mechanism. Hypertension 45:780-785.
6. Ministry of the Environment (MOE), Government of Japan. 2007. Report on the effect of the exposure to fine particulate matter. 160-167. (Japanese)
7. Morrell NW, Morris KG, Stenmark KR. 1995. Role of angiotensinconverting enzyme and angiotensin II in development of hypoxic pulmonary hypertension. Am J Physiol 269:H1186-H1194.
8. Nadziejko C, Fang K, Narciso S, Zhong M, Su WC, Gordon T, Nádas A, Chen LC. 2004. Effect of particulate and gaseous pollutants on spontaneous arrhythmias in aged rats. Inhal Toxicol 16:373-380.
9. Oberdörster G, Oberdörster E, Oberdörster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
10. Orte C, Polak JM, Haworth SG, Yacoub MH, Morrell NW. 2000. Expression of pulmonary vascular angiotensin-converting enzyme in primary and secondary plexiform pulmonary hypertension. J Pathol 192:379-384.
11. Peters A, Dockery DW, Muller JE, Mittleman MA. 2001. Increased particulate air pollution and the triggering of myocardial infarction. Circulation 103:2810-2815.
12. Pope CA 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD. 2002. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 287:1132-1141.
13. Sakamoto N, Hayashi S, Gosselink J, Ishii H, Ishimatsu Y, Mukae H, Hogg JC, van Eeden SF. 2007. Calcium dependent and independent cytokine synthesis by air pollution particle-exposed human bronchial epithelial cells. Toxicol Appl Pharmacol 225:134-141.
14. Schwartz J, Dockery DW, Neas LM. 1996. Is daily mortality associated specifically with fine particles? J Air Waste Manag Assoc 46:927-939.
15. Silva AP, Cavadas C, Grouzmann E. 2002. Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin Chim Acta 326:3-25.
16. Sioutas C, Koutrakis P, Burton RM. 1995. A technique to expose animals to concentrated fine ambient aerosols. Environ Health Perspect 103:172-177.
17. Stenmark KR, Mecham RP. 1997. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu Rev Physiol 59:89-144.
18. Stimler NP, Hugli TE, Bloor CM. 1980. Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol 100:327-348.
19. Valavanidis A, Fiotakis K, Vlachogianni T. 2008. Airborne particulate matter and human health: toxicological assessment and importance of size and composition of particles for oxidativedamage and arcinogenic mechanisms. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 26:339-362.
20. Wösten-van Asperen RM, Lutter R, Specht PA, van Woensel JB, van der Loos CM, Florquin S, Lachmann B, Bos AP. 2010. Ventilatorinduced inflammatory response in lipopolysaccharide-exposed rat lung is mediated by angiotensin-converting enzyme. Am J Pathol 176:2219-2227.
21. Zelikoff JT, Chen LC, Cohen MD, Fang K, Gordon T, Li Y, Nadziejko C, Schlesinger RB. 2003. Effects of inhaled ambient particulate matter on pulmonary antimicrobial immune defense. Inhal Toxicol 15:131-150.